A new study published in the European Archives of Oto-Rhino-Laryngology revealed that serum 25(OH)D deficiency is an ...

As a high school teacher and baseball coach, Steve Loutzenhiser is used to an active life, describing himself as “super ...

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

TIL therapy is FDA-approved as a second or third option for patients with advanced melanoma. Gibney said in the future, the ...

The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with glioma, the most ... Feb. 11, 2025 — Scientists have developed an innovative method for growing ...

These metastases typically indicate advanced cancer, with 31 of the 72 examined patients already showing systemic spread of the primary tumour at the time of penile metastasis diagnosis.

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Elahere shows a 37% lower risk of tumor progression or death vs. chemotherapy, with a median PFS of 5.59 months vs. 3.98 months. Patients on Elahere have a median overall survival of 16.85 months ...

March is colon cancer awareness month. The disease is the second leading cause of cancer deaths in the U.S. according to the ...

The broadcaster shared her upcoming plans, which include "a double mastectomy" and "getting back in the gym" Omar Vega/Getty Kat Timpf is hopeful amid her breast cancer diagnosis. On Friday ...